These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 32660502)

  • 1. An observational study of initial HIV RNA decay following initiation of combination antiretroviral treatment during pregnancy.
    Alagaratnam J; Peters H; Francis K; Kay N; Gilleece Y; Finnerty FP; Grimes RE; Parry S; Portman M; Wait BC; Shah R; Roedling S; Hawkins DA; Chitty S; Sarner L; Marcus R; Hartley A; Nori AV; Rosenvinge M; Taylor GP;
    AIDS Res Ther; 2020 Jul; 17(1):41. PubMed ID: 32660502
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of the frequency of plasma viral load monitoring on treatment outcomes among children with perinatally acquired HIV.
    Sudjaritruk T; Boettiger DC; Nguyen LV; Mohamed TJ; Wati DK; Bunupuradah T; Hansudewechakul R; Ly PS; Lumbiganon P; Nallusamy RA; Fong MS; Chokephaibulkit K; Nik Yusoff NK; Truong KH; Do VC; Sohn AH; Sirisanthana V;
    J Int AIDS Soc; 2019 Jun; 22(6):e25312. PubMed ID: 31179641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preterm delivery risk in women initiating antiretroviral therapy to prevent HIV mother-to-child transmission.
    Short CE; Douglas M; Smith JH; Taylor GP
    HIV Med; 2014 Apr; 15(4):233-8. PubMed ID: 24025074
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [National consensus document by GESIDA/National Aids Plan on antiretroviral treatment in adults infected by the human immunodeficiency virus (January 2011 update)].
    Panel de expertos de GESIDA y Plan Nacional sobre el Sida
    Enferm Infecc Microbiol Clin; 2011 Mar; 29(3):209.e1-103. PubMed ID: 21388714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does pregnancy affect the early response to cART?
    Rachas A; Warszawski J; Le Chenadec J; Legeai C; Teglas JP; Goujard C; Rouzioux C; Mandelbrot L; Tubiana R; Meyer L
    AIDS; 2013 Jan; 27(3):357-67. PubMed ID: 23079802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [GESIDA/National AIDS Plan: Consensus document on antiretroviral therapy in adults infected by the human immunodeficiency virus (Updated January 2015)].
    Panel de expertos de GeSIDA y Plan Nacional sobre el Sida
    Enferm Infecc Microbiol Clin; 2015 Oct; 33(8):543.e1-43. PubMed ID: 25959461
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brief Report: Vaginal Viral Shedding With Undetectable Plasma HIV Viral Load in Pregnant Women Receiving 2 Different Antiretroviral Regimens: A Randomized Clinical Trial.
    Frenkel LM; Morrison RL; Fuller TL; Gouvêa MI; Benamor Teixeira ML; Coombs RW; Shapiro DE; Mirochnick M; Hennessey R; Whitson K; Chakhtoura N; João EC
    J Acquir Immune Defic Syndr; 2021 Dec; 88(4):361-365. PubMed ID: 34369908
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiretroviral Regimen Durability and Success in Treatment-Naive and Treatment-Experienced Patients by Year of Treatment Initiation, United States, 1996-2011.
    Sheth AN; Ofotokun I; Buchacz K; Armon C; Chmiel JS; Hart RL; Baker R; Brooks JT; Palella FJ
    J Acquir Immune Defic Syndr; 2016 Jan; 71(1):47-56. PubMed ID: 26334737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. When should HAART be initiated in pregnancy to achieve an undetectable HIV viral load by delivery?
    Read PJ; Mandalia S; Khan P; Harrisson U; Naftalin C; Gilleece Y; Anderson J; Hawkins DA; Taylor GP; de Ruiter A;
    AIDS; 2012 Jun; 26(9):1095-103. PubMed ID: 22441248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Consensus document of Gesida and Spanish Secretariat for the National Plan on AIDS (SPNS) regarding combined antiretroviral treatment in adults infected by the human immunodeficiency virus (January 2012)].
    Panel de expertos de Gesida y Plan Nacional sobre el Sida
    Enferm Infecc Microbiol Clin; 2012 Jun; 30(6):e1-89. PubMed ID: 22633764
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early Initiation of Antiretroviral Therapy Following In Utero HIV Infection Is Associated With Low Viral Reservoirs but Other Factors Determine Viral Rebound.
    Millar JR; Bengu N; Vieira VA; Adland E; Roider J; Muenchhoff M; Fillis R; Sprenger K; Ntlantsana V; Fatti I; Archary M; Groll A; Ismail N; García-Guerrero MC; Matthews PC; Ndung'u T; Puertas MC; Martinez-Picado J; Goulder P
    J Infect Dis; 2021 Dec; 224(11):1925-1934. PubMed ID: 33963757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term effectiveness of initiating non-nucleoside reverse transcriptase inhibitor- versus ritonavir-boosted protease inhibitor-based antiretroviral therapy: implications for first-line therapy choice in resource-limited settings.
    Lima VD; Hull M; McVea D; Chau W; Harrigan PR; Montaner JS
    J Int AIDS Soc; 2016; 19(1):20978. PubMed ID: 27499064
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of two combined antiretroviral treatment regimens in the management of HIV in pregnancy: an observational study.
    Tate DL; Sublette NK; Christiansen ME; Samson FD; Wang JQ; Rodriguez M; Seif K; Salama R; Gomez LM
    J Matern Fetal Neonatal Med; 2021 Nov; 34(22):3723-3729. PubMed ID: 31709863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.
    Volmink J; Siegfried NL; van der Merwe L; Brocklehurst P
    Cochrane Database Syst Rev; 2007 Jan; (1):CD003510. PubMed ID: 17253490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Virological Response and Drug Resistance 1 and 2 Years Post-Partum in HIV-Infected Women Initiated on Life-Long Antiretroviral Therapy in Malawi.
    Mancinelli S; Galluzzo CM; Andreotti M; Liotta G; Jere H; Sagno JB; Amici R; Pirillo MF; Scarcella P; Marazzi MC; Vella S; Palombi L; Giuliano M
    AIDS Res Hum Retroviruses; 2016 Aug; 32(8):737-42. PubMed ID: 27067142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Viral dynamics after starting first-line HAART in HIV-1-infected children.
    Bekker V; Scherpbier HJ; Steingrover R; Jurriaans S; Lange JM; Wolthers KC; Kuijpers TW
    AIDS; 2006 Feb; 20(4):517-23. PubMed ID: 16470115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dual nucleoside reverse transcriptase inhibitor therapy in the combination antiretroviral therapy era and predictors of discontinuation or switch to combination antiretroviral therapy.
    Selinger-Leneman H; Matheron S; Mahamat A; Moreau J; Costagliola D; Abgrall S;
    J Acquir Immune Defic Syndr; 2008 Feb; 47(2):206-11. PubMed ID: 17971717
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genital tract HIV-1 RNA shedding among women with below detectable plasma viral load.
    Cu-Uvin S; DeLong AK; Venkatesh KK; Hogan JW; Ingersoll J; Kurpewski J; De Pasquale MP; D'Aquila R; Caliendo AM
    AIDS; 2010 Oct; 24(16):2489-97. PubMed ID: 20736815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The 48-week efficacy of once-daily saquinavir/ritonavir in patients with undetectable viral load after 3 years of antiretroviral therapy.
    Cardiello P; Srasuebkul P; Hassink E; Mahanontharit A; Samor T; Ruxrungtham K; Lange J; Cooper D; Phanuphak P
    HIV Med; 2005 Mar; 6(2):122-8. PubMed ID: 15807718
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of baseline HIV-1 RNA, drug resistance, and regimen type as determinants of response to first-line antiretroviral therapy.
    Di Biagio A; Rusconi S; Marzocchetti A; Signori A; Schiavetti I; Bruzzone B; Monno L; Punzi G; Colao MG; Penco G; Zazzi M; De Luca A;
    J Med Virol; 2014 Oct; 86(10):1648-55. PubMed ID: 25042976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.